COVID-19 Impact on Global Recombinant Vaccines Market By Patient Type (Pediatric and Adult Patients); By Technology (Conjugate Vaccines, Inactivated And Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines and Toxoid Vaccines) and Region -Analysis of Market Size, Share and Trends for 2014 - 2019 and Forecasts to 2030
By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
Recombinant Vaccines Market: Market Segmentation
By Regions
North America:(U.S. and Canada)
By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
Latin America: (Brazil, Mexico, Argentina, Rest of Latin America)
By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe)
By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific)
By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa)
By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
Recombinant Vaccines Market: Market Segmentation
By technology: Market Share (2020-2030F)
conjugate vaccines, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
inactivated and subunit vaccines, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
live attenuated vaccines, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
recombinant vaccines, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
toxoid vaccines, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
By patient type : Market Share (2020-2030F)
pediatric, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
adult patients, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F
Company Profile
Johnson and Johnson
Company Overview
Company Total Revenue (Financials)
Market Potential
Global Presence
Key Performance Indicators
SWOT Analysis
Product Launch
Abiomed
Emergent Bio Solutions, Inc.
GlaxoSmithKline
Sanofi Pasteur SA
Serum Institute of India Pvt. Ltd
Mitsubishi Tanabe Pharma Corporation
Daiichi Sankyo
Pfizer, Inc.
Other prominent players
Consultant Recommendation
**The above-given segmentation and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
We have been working with some Fortune 500+ clients
We Respect Your Privacy
Fatpos Global is committed to providing a secure, transparent, and user-friendly browsing experience. To continue improving our website and services, we request your consent for the use of cookies. Below are the types of cookies we utilize:
These cookies are required for the website to operate smoothly and are always enabled. They help maintain core functionalities, remember your basic preferences, and ensure a safe and seamless user experience.
These cookies help us understand how users interact with our content. By analyzing page visits and user engagement, we can continuously refine our platform and deliver more relevant insights, articles, and resources.
These cookies do not collect personally identifiable information. Instead, they recognize your browser or device to display content that may be relevant to your interests on our site or through selected partners, including social media and advertising networks.